About Ancilia Bio
Ancilia Bio is a private company based in New York, New York. It has reported $11,076,464 raised in two offerings on Form D since May 2023. Its chief executive is Alexandra Sakatos.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 13, 2026 | Apr 6, 2026 | $10,076,464fully sold | 23 | $438K | EquityRule 506(b) | Form D ↗ |
| Apr 13, 2023 | May 4, 2023 | $1,000,000of $5.0M target | 2 | $500K | DebtRule 506(b) | Form D ↗ |
| Total, two offerings | $11,076,464 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Ancilia Bio's Form D filed Apr 6, 2026.
DP
VS
Gurdane Bhutani
Director
Also a managing partner and director at Contraline and a director at Junction Health.